These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 18790023)

  • 1. The search for a role of the caudal intralaminar nuclei in the pathophysiology of Parkinson's disease.
    Lanciego JL; López IP; Rico AJ; Aymerich MS; Pérez-Manso M; Conte L; Combarro C; Roda E; Molina C; Gonzalo N; Castle M; Tuñón T; Erro E; Barroso-Chinea P
    Brain Res Bull; 2009 Feb; 78(2-3):55-9. PubMed ID: 18790023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson's disease.
    Kerkerian-Le Goff L; Bacci JJ; Jouve L; Melon C; Salin P
    Brain Res Bull; 2009 Feb; 78(2-3):80-4. PubMed ID: 18790021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states.
    Smith Y; Raju D; Nanda B; Pare JF; Galvan A; Wichmann T
    Brain Res Bull; 2009 Feb; 78(2-3):60-8. PubMed ID: 18805468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the caudal intralaminar nuclei for functional neurosurgery of movement disorders.
    Benabid AL
    Brain Res Bull; 2009 Feb; 78(2-3):109-12. PubMed ID: 18812212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex.
    Stefani A; Peppe A; Pierantozzi M; Galati S; Moschella V; Stanzione P; Mazzone P
    Brain Res Bull; 2009 Feb; 78(2-3):113-8. PubMed ID: 18812214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the thalamic CM-PF complex-Basal ganglia circuit in externally driven rebias of action.
    Minamimoto T; Hori Y; Kimura M
    Brain Res Bull; 2009 Feb; 78(2-3):75-9. PubMed ID: 18793702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The primate centromedian-parafascicular complex: anatomical organization with a note on neuromodulation.
    Sadikot AF; Rymar VV
    Brain Res Bull; 2009 Feb; 78(2-3):122-30. PubMed ID: 18957319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facing the lack of anti-phase oscillation in the parafascicular nucleus after dopamine depletion.
    Tseng KY
    Exp Neurol; 2009 Sep; 219(1):62-5. PubMed ID: 19501087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalamic changes in Parkinson's disease.
    Halliday GM
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S152-5. PubMed ID: 20082979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional anatomy of thalamus and basal ganglia.
    Herrero MT; Barcia C; Navarro JM
    Childs Nerv Syst; 2002 Aug; 18(8):386-404. PubMed ID: 12192499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The centromedian nucleus: Anatomy, physiology, and clinical implications.
    Ilyas A; Pizarro D; Romeo AK; Riley KO; Pati S
    J Clin Neurosci; 2019 May; 63():1-7. PubMed ID: 30827880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralaminar nuclei of the thalamus in Lewy body diseases.
    Brooks D; Halliday GM
    Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.
    Braak H; Del Tredici K
    Exp Neurol; 2008 Jul; 212(1):226-9. PubMed ID: 18501351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of the basal ganglia and movement disorders: from animal models to human clinical applications.
    Israel Z; Bergman H
    Neurosci Biobehav Rev; 2008; 32(3):367-77. PubMed ID: 17949812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional models of movement disorders of basal ganglia origin and effects of functional neurosurgery].
    Hashimoto T
    Rinsho Shinkeigaku; 2007 Jan; 47(1):21-6. PubMed ID: 17491332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring and switching of cortico-basal ganglia loop functions by the thalamo-striatal system.
    Kimura M; Minamimoto T; Matsumoto N; Hori Y
    Neurosci Res; 2004 Apr; 48(4):355-60. PubMed ID: 15041188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia.
    Truong L; Brooks D; Amaral F; Henderson JM; Halliday GM
    Mov Disord; 2009 Oct; 24(14):2128-35. PubMed ID: 19735086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
    Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
    Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.